A pilot study to implement epigenetically active treatment in the care of patients with unresectable or metastasized pancreatic ductal adenocarcinoma

Registry ID

DRKS00031481

Source registry

DRKS

Status

RECRUITING

Sponsor

Universitätsklinikum Freiburg

Enrollment

30

Start date

2023-04-01

Last update

2026-08-14

Conditions

• Malignant neoplasm of pancreas

Inclusion criteria

Unresectable or metastasized pancreatic ductal adenocarcinoma

Exclusion criteria

Alter < 18 Jahre

Primary outcomes

Evaluation of biomarkers in context of baseline disease features and outcome

Locations

• , , DE

Related clinical trials

• Impact of a restructured patient education on the Comprehension, Awareness and patient satisfaction in the setting of pancREatic resection
• Evaluation of training offers within the framework of the Center for Competence Development in Cancer Self-Help (ZfK KSH)
• Evaluation of molecular markers to predict the pattern of tumor recurrence and prognosis in pancreatric ductal adenocarcinoma
• Short-term fasting and individualized nutrition accompanying chemotherapy for metastatic pancreatic cancer – a randomised controlled 2-arm intervention study
• Consolidative MR-Guided Adaptive Radiotherapy Combined with Hyperthermia in Locally Advanced Pancreatic Cancer Patients Not Suitable for Resection After Induction Chemotherapy
• Molecular Fingerprinting in Cancer Detection

View on source registry